News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aastrom Biosciences, Inc. (ASTM) to Host Second Quarter 2012 Investor Call on August 7, 2012



8/3/2012 10:24:39 AM

ANN ARBOR, Mich., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific, expanded multicellular therapies for the treatment of severe, chronic cardiovascular diseases, will hold a second quarter investor call on Tuesday, August 7, 2012 at 4:30 pm (EDT). Dr. Grayson Wheatley, III, MD, FACS, of the Arizona Heart Institute, will join Aastrom's senior management on the call to discuss his experience treating patients with critical limb ischemia and his participation in Aastrom's clinical development programs for CLI.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES